试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-09
A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478
编号:NCT04452006登记状态:提前终止企业 / 申办者:Idorsia Pharmaceuticals Ltd.
药物 / 成分:ACT-541478 10 mg、ACT-541478 30 mg、ACT-541478 100 mg、ACT-541478 300 mg
登记的停止原因(原文):Based on interim analysis, the Sponsor decided to terminate the study prematurely.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-08
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
编号:NCT01784861登记状态:提前终止企业 / 申办者:Washington University School of Medicine
药物 / 成分:X-82、Everolimus
登记的停止原因(原文):Pharmaceutical company decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-08
Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
编号:NCT02382588登记状态:提前终止企业 / 申办者:Northwestern University
药物 / 成分:gancyclovir gel、Hypromellose gel
登记的停止原因(原文):There were difficulties meeting the enrollment goal within stipulated time frames.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-08
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
编号:NCT02565511登记状态:提前终止企业 / 申办者:Novartis Pharmaceuticals
药物 / 成分:CAD106 Immunotherapy、Placebo to CAD106、CNP520、Placebo to CNP520
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-08
Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
编号:NCT03040024登记状态:提前终止企业 / 申办者:Emory University
药物 / 成分:Ketamine、Placebo、Electroencephalogram (EEG)
登记的停止原因(原文):Halted due to COVID 19; we believe we have adequate data for analysis
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-08
A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.
编号:NCT03802227登记状态:提前终止企业 / 申办者:Nektar Therapeutics
药物 / 成分:NKTR-181、Oxycodone IR
登记的停止原因(原文):Sponsor Decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-07
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
编号:NCT01070888登记状态:提前终止企业 / 申办者:Boston Children's Hospital
药物 / 成分:Budesonide/Formoterol、Budesonide
登记的停止原因(原文):Unable to reach target goal
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-07
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
编号:NCT01108666登记状态:提前终止企业 / 申办者:Abramson Cancer Center at Penn Medicine
药物 / 成分:Nelfinavir
登记的停止原因(原文):Insufficient accrual
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-07
Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
编号:NCT02230527登记状态:提前终止企业 / 申办者:The Cleveland Clinic
药物 / 成分:Ticagrelor、Clopidogrel
登记的停止原因(原文):Lack of enrollment
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-07-07
Intranasal Insulin for the Treatment of HAND
编号:NCT03081117登记状态:提前终止企业 / 申办者:Johns Hopkins University
药物 / 成分:Insulin, intranasal、Placebo, intranasal
登记的停止原因(原文):On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH.
查看官方原始记录 ↗